Skip to Content

Sartorius AG Vorz-Inhaber-Akt ohne Stimmrecht SUVPF

Morningstar Rating
$355.48 −12.53 (3.40%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

SUVPF is trading at a 9% discount.
Price
$367.64
Fair Value
$315.64
Uncertainty
High
1-Star Price
$644.56
5-Star Price
$611.81
Economic Moat
Yhgc
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SUVPF is a good fit for your portfolio.

Trading Information

Previous Close Price
$368.00
Day Range
$355.48355.48
52-Week Range
$223.00423.70
Bid/Ask
$340.60 / $364.95
Market Cap
$24.32 Bil
Volume/Avg
3 / 201

Key Statistics

Price/Earnings (Normalized)
119.86
Price/Sales
3.43
Dividend Yield (Trailing)
0.22%
Dividend Yield (Forward)
0.24%
Total Yield
0.22%

Company Profile

Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Large Growth
Total Number of Employees
14,614

Competitors

Valuation

Metric
SUVPF
MRK
MTD
Price/Earnings (Normalized)
119.8620.0432.26
Price/Book Value
11.022.50
Price/Sales
3.433.187.12
Price/Cash Flow
19.3414.8729.51
Price/Earnings
SUVPF
MRK
MTD

Financial Strength

Metric
SUVPF
MRK
MTD
Quick Ratio
0.620.790.62
Current Ratio
1.471.421.04
Interest Coverage
3.6311.3213.59
Quick Ratio
SUVPF
MRK
MTD

Profitability

Metric
SUVPF
MRK
MTD
Return on Assets (Normalized)
4.16%7.55%24.53%
Return on Equity (Normalized)
16.78%13.81%
Return on Invested Capital (Normalized)
6.93%10.19%44.03%
Return on Assets
SUVPF
MRK
MTD
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ISRG
Intuitive Surgical IncCdcnvrjfrfYdxlk$134.2 Bil
BDX
Becton Dickinson & CoKwqfcwgPlkfzg$67.9 Bil
ALC
Alcon IncNvqxlnhgMthdpp$39.5 Bil
CLPBY
Coloplast A/S ADRKjlvmthprsHfmj$29.4 Bil
WST
West Pharmaceutical Services IncStzwrfwxVdrvh$27.8 Bil
RMD
ResMed IncNlqhrpcmzQgwrpb$27.2 Bil
BAX
Baxter International IncFpxjpvspLbwrgvn$20.2 Bil
COO
The Cooper Companies IncJvzbjttjBlkrhl$18.0 Bil
HOLX
Hologic IncBvfxjpgRjbzyn$17.6 Bil
TFX
Teleflex IncDkncsMyps$9.9 Bil

Sponsor Center